Roche Shares Boosted by Cancer Drug Trial Success

Roche shares rose sharply after the company reported a clinical trial success that could help cushion it against looming competition for Herceptin and boost sales for its newer Perjeta drug.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: FREE Source Type: news